[Rich66]

Chelee,
My tongue was firmly in cheek regarding the identity of Dr. Slamon. I requested my mom's recurrence pathology to be sent for 2nd opinion from a reluctant Wisconsin onc to Slamon's pathologist, Michael Press. I am aware. But I am also aware I haven't received an explanation of Press's recent comments suggesting borderline Her2 may benefit equally from Herceptin. That is different from what was said up until recently and deserves clarification, and I asked for it...without even a response. Good things came from Slamon's Herceptin endeavor...yet the response rate is less than ideal and it seems to be murky terrritory. I have come to realize all is in flux in cancer world. Human nature/egos/guarded protocols remain players in what we all would like to be hard, yet comforting science.